galantamine has been researched along with Protein Aggregation, Pathological in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, LY; Lan, JS; Li, SY; Pan, LF; Wang, XB; Xie, SS | 1 |
| Emoto, MC; Fujii, HG; Hisahara, S; Iwahara, N; Kawamata, J; Manabe, T; Matsumura, A; Matsushita, T; Saito, T; Sato-Akaba, H; Shimohama, S; Suzuki, H; Suzuki, S; Yokokawa, K | 1 |
2 other study(ies) available for galantamine and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blood-Brain Barrier; Butyrylcholinesterase; Carbolines; Cell Line; Chelating Agents; Cholinesterase Inhibitors; Drug Design; Electrophorus; Horses; Humans; Molecular Docking Simulation; Protein Aggregation, Pathological; Tacrine | 2014 |
Early administration of galantamine from preplaque phase suppresses oxidative stress and improves cognitive behavior in APPswe/PS1dE9 mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Galantamine; Humans; Inflammation; Mice; Microglia; Oxidative Stress; Protein Aggregation, Pathological; Reactive Oxygen Species; Ribosomal Proteins; RNA-Binding Proteins | 2019 |